IPEC’s EIP user guide streamlines information exchange and response times while increasing accuracy through standardization.
Joseph Zeleznik
Advertisement
Joseph Zeleznik is technical product director, IMCD US
Articles by Joseph Zeleznik
Understanding how factors such as excipient choice affect nitrosamine formation is essential to developing safer, lower-risk pharmaceutical formulations.
Key information is needed for excipients and their potential impact on continuous manufacturing processes.
Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
Advertisement
Latest Updated Articles
Understanding Concomitant Components in Pharmaceutical ExcipientsFebruary 2nd 2021
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Improving Oral Peptide Delivery Through Structural Modifications
2
Regulatory Roundup—October 2026: FDA Advances Rare Disease Development and Transparency Efforts
3
Using OEE Monitoring to Justify Expenditure on Aging Production Lines
4
RRP Accelerated Approval: What VOCERYQ Means for Manufacturing Teams
5